论文部分内容阅读
Background To observe the recent clinical effects of native bioabsorbable polymer Rapamycin-eluting stent (Excel) for treating coronary heart disease (CHD).Methods From February 2007 to October 2008, a total of 127 consecutive patients with CHD who received Excel stent implantation,185 Excel stents were implanted in 152 criminal-related arteries.Followed-up was done for 3-6 months through outpatient department and telephone equipment.The major adverse cardiac events (MACE) including cardic death, non-fatal myocardial infarction or target vessel revascularization and clinical symptoms were the targets we wanted to observe.1.